Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cancer Investigation|August 29, 2002
Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomasJohn H Edmonson, Randolph S Marks, Jan C Buckner, et al.Cancer|April 4, 2003
Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology GroupScott Okuno, Louise M Ryan, John H Edmonson, et al.Sarcoma|June 4, 2008
Phase II Study of Ifosfamide+Doxorubicin in Patients With Advanced Synovial Sarcomas (E1793): A Trial of the Eastern Cooperative Oncology GroupJohn H Edmonson, Louise M Ryan, Carla I Falkson, et al.Gynecologic Oncology|June 8, 2002
Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group studyJohn H Edmonson, John A Blessing, Jonathan A Cosin, et al.Cancer|May 10, 2002
Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neckScott H Okuno, James A Mailliard, Vera J Suman, et al.Cancer|August 5, 2005
Intraabdominal desmoplastic small round cell tumors: a diagnostic and therapeutic challengeImran Hassan, Roman Shyyan, John H Donohue, et al.Cancer|February 22, 2002
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factorJohn H Edmonson, Ivy A Petersen, Thomas C Shives, et al.Pageof 1